Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Cimzia Market Revenue Growth Supported By A CAGR Of % Through 2030
The cimzia market has experienced significant expansion in the near term, with projections moving from $3.57 million in 2025 to $4.19 million by 2026, reflecting a compound annual growth rate (CAGR) of 17.6%. Historical growth has been driven by the approval of TNF inhibitors, an increase in autoimmune disease incidence, the limited efficacy of traditional treatments, prescribing behaviors among specialists, and the integration of biologics within hospital settings.
The market for Cimzia is projected to experience strong growth over the coming years. By 2030, its value is anticipated to reach $7.94 million, driven by a compound annual growth rate (CAGR) of 17.3%. Several factors will fuel this expansion in the forecast period, including the development of biologic treatment protocols, a rise in autoimmune disorder diagnoses, heightened biosimilar competition, a growing patient preference for targeted therapies, and better reimbursement policies. Key trends shaping this period encompass the wider adoption of TNF inhibitor biologics, the increasing application of Cimzia across multiple autoimmune conditions, a transition towards therapies focused on long-term disease control, greater acceptance of self-administered injectable biologics, and an enhanced emphasis on improving patient quality of life.
Download A Free Sample Report For Comprehensive Market Insights:
Cimzia Market Growth Factors Supporting Long-Term Expansion
The anticipated growth of the Cimzia market is being fueled by an increasing incidence of rheumatoid arthritis. This chronic autoimmune condition occurs when the immune system erroneously attacks joint tissues, resulting in inflammation, discomfort, and swelling. Several factors contribute to its rising prevalence, including an older demographic, heightened genetic susceptibility, environmental influences such as smoking and pollution, along with better awareness and diagnostic capabilities. Cimzia plays a vital role in combating this trend by providing focused treatment that lowers inflammation, relieves symptoms, improves patients’ quality of life, and facilitates more effective disease control. As an example, February 2024 data from Arthritis WA, an Australian organization, indicated that by 2025, RA cases are projected to reach approximately 212,136 men and 362,137 women, with estimates for 2040 climbing to around 280,040 men and 479,828 women. Consequently, the growing prevalence of rheumatoid arthritis is a key factor driving the expansion of the Cimzia market.
The growing number of elderly individuals is set to boost the Cimzia market’s expansion moving forward. This phenomenon, described as an aging population, involves a rising share of older people within a community, driven by longer life spans and reduced birth rates. Enhanced medical care, which has increased longevity, is behind this demographic shift. Older adults turn to Cimzia to address persistent inflammatory disorders such as arthritis, which helps lessen pain and enhance their ability to move. For instance, January 2024 findings from the Population Reference Bureau, a US-based nonprofit, revealed that Americans aged 65 and over are predicted to increase from 58 million in 2022 to 82 million by 2050, representing a 47% rise. Furthermore, this cohort’s share of the overall US population is anticipated to expand from 17% to 23% over the same timeframe. Hence, the rising elderly demographic is propelling the growth of the Cimzia market.
Cimzia Market Segments: Where Are The Largest Growth Opportunities?
The cimzia market covered in this report is segmented –
1) By Type: Biologics, Biosimilars
2) By Patient Demographics: Adults, Pediatrics
3) By Distribution Channels: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Pharmacies
4) By Application: Crohn’s Disease, Rheumatoid Arthritis, Ankylosing Spondylitis, Active Psoriatic Arthritis, Axial Spondyloarthritis, Plaque Psoriasis
Cimzia Market Industry Trends Shaping Future Revenue Growth
Major players in the Cimzia market are concentrating on creating cutting-edge therapies, like autoimmune treatment solutions, to broaden the therapeutic choices for patients dealing with non-radiographic axial spondyloarthritis, thereby tackling an unmet need in the management of autoimmune conditions. These autoimmune therapy solutions are designed to regulate autoimmune diseases by reinstating immune equilibrium and tolerance, typically through the use of focused immunotherapies and cell-based treatments. As an example, in July 2024, UCB, a biopharmaceutical firm headquartered in Belgium, revealed the extension of CIMZIA (certolizumab pegol) as a therapeutic alternative for individuals with non-radiographic axial spondyloarthritis (nr-axSpA). This move is intended to deliver an advanced therapy option for those who lack radiographic evidence of the condition yet still face ongoing symptoms. CIMZIA stands as the initial and sole biologic granted FDA approval for nr-axSpA, underscoring its distinctive role in the autoimmune therapeutic arena. This approval provides a vital substitute to conventional treatments, aiding patients with this inflammatory disorder in achieving better symptom control and enhanced quality of life.
Cimzia Market Major Participants And Competitive Dynamics
Major companies operating in the cimzia market are UCB SA
Access The Complete Cimzia Market Report:
Cimzia Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the cimzia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cimzia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model